U.S. markets open in 9 hours 19 minutes
  • S&P Futures

    4,430.25
    -2.75 (-0.06%)
     
  • Dow Futures

    34,770.00
    +27.00 (+0.08%)
     
  • Nasdaq Futures

    15,149.00
    -45.75 (-0.30%)
     
  • Russell 2000 Futures

    2,281.00
    +4.00 (+0.18%)
     
  • Crude Oil

    76.11
    +0.66 (+0.87%)
     
  • Gold

    1,749.50
    -2.50 (-0.14%)
     
  • Silver

    22.61
    -0.08 (-0.37%)
     
  • EUR/USD

    1.1696
    -0.0005 (-0.05%)
     
  • 10-Yr Bond

    1.4840
    +0.0240 (+1.64%)
     
  • Vix

    18.76
    +1.01 (+5.69%)
     
  • GBP/USD

    1.3706
    +0.0002 (+0.01%)
     
  • USD/JPY

    111.1900
    +0.2120 (+0.19%)
     
  • BTC-USD

    42,678.25
    -1,384.07 (-3.14%)
     
  • CMC Crypto 200

    1,057.18
    -44.34 (-4.03%)
     
  • FTSE 100

    7,063.40
    +11.92 (+0.17%)
     
  • Nikkei 225

    30,130.50
    -109.56 (-0.36%)
     

Who Has Been Buying Yield10 Bioscience, Inc. (NASDAQ:YTEN) Shares?

  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On the other hand, we'd be remiss not to mention that insider sales have been known to precede tough periods for a business. So before you buy or sell Yield10 Bioscience, Inc. (NASDAQ:YTEN), you may well want to know whether insiders have been buying or selling.

What Is Insider Selling?

It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, such insiders must disclose their trading activities, and not trade on inside information.

We don't think shareholders should simply follow insider transactions. But equally, we would consider it foolish to ignore insider transactions altogether. For example, a Columbia University study found that 'insiders are more likely to engage in open market purchases of their own company’s stock when the firm is about to reveal new agreements with customers and suppliers'.

Check out our latest analysis for Yield10 Bioscience

The Last 12 Months Of Insider Transactions At Yield10 Bioscience

In the last twelve months, the biggest single purchase by an insider was when insider Jack Schuler bought US$1.6m worth of shares at a price of US$4.25 per share. We do like to see buying, but this purchase was made at well below the current price of US$16.49. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.

Jack Schuler bought 375.09k shares over the last 12 months at an average price of US$4.35. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
insider-trading-volume

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Insider Ownership of Yield10 Bioscience

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. Yield10 Bioscience insiders own about US$13m worth of shares. That equates to 23% of the company. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

So What Do The Yield10 Bioscience Insider Transactions Indicate?

It doesn't really mean much that no insider has traded Yield10 Bioscience shares in the last quarter. On a brighter note, the transactions over the last year are encouraging. Insiders own shares in Yield10 Bioscience and we see no evidence to suggest they are worried about the future. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. When we did our research, we found 4 warning signs for Yield10 Bioscience (2 are a bit unpleasant!) that we believe deserve your full attention.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.